Thu Oct 23 11:35:43 UTC 2025: Here’s a summarized news article based on the provided text:
Headline: AIG Hospitals Launches Affordable Pharmacogenomics Test, Tailoring Medication to Individual DNA
Hyderabad, October 23, 2025: AIG Hospitals, in collaboration with GenepoweRx, has introduced a groundbreaking pharmacogenomics test in India, priced at ₹5,000. This affordable test analyzes an individual’s genetic makeup to predict their response to various medications, enabling doctors to prescribe drugs tailored to their unique genetic profile.
Unlike generic prescribing practices, the test considers how each person metabolizes drugs differently, potentially preventing ineffective or harmful treatments. It analyzes genes related to medication response for heart disease, diabetes, cancer, gastrointestinal disorders, neurological and psychiatric conditions, and pain management.
A study involving over 2,000 patients revealed that nearly 30% were taking medications unsuited to their genetic makeup. The new test aims to address this issue by providing a personalized report that can be used throughout a patient’s life, informing future prescriptions.
The process involves a 2 ml blood sample, DNA extraction, and genomic data analysis. The test uses both Indian patient study data and UK Biobank data to account for genetic variations specific to the Indian population. Results are typically available within 12-13 days.
According to Dr. Nageshwar Reddy, chairman of AIG Hospitals, the test not only offers affordability but also has the potential to reduce pharmaceutical costs by preventing over-prescription and minimizing complications from adverse drug reactions.
First Piper 